Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection

Clinical and Vaccine Immunology

Volumn 19, Issue 5, 2012, Pages 780-786

  Abdelwahab, Sayed F ^a,b   Zakaria, Zainab ^b   Sobhy, Maha ^b   Rewisha, Eman ^c   Mahmoud, Mohamed A ^c   Amer, Mahmoud A ^d   Del Sorbo, Mariarosaria ^e   Capone, Stefania ^e   Nicosia, Alfredo ^e,f,g   Folgori, Antonella ^e   Mohamed Hashem, ^b,h   El Kamary, Samer S ^h  

^a Minia University   (Egypt)

^b Egyptian Company for Blood Transfusion Services (Egyblood)/VACSERA   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

^e Okairos ^*  (Italy)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS C ANTIGEN; PARASITE ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EGYPTIAN; EMPLOYMENT; ENZYME LINKED IMMUNOSPOT ASSAY; ETHNICITY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; NEEDLESTICK INJURY; NURSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RURAL POPULATION; SCHISTOSOMA MANSONI; SEROCONVERSION; T LYMPHOCYTE; VIRAL CLEARANCE; VIREMIA; VIRUS DETECTION; VIRUS GENOME;

ADULT; ANTIGENS, CD4; EGYPT; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HEALTH PERSONNEL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MALE; RNA, VIRAL; T-LYMPHOCYTES; VIREMIA;

EID: 84860321245     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00050-12     Document Type: Article

References (52)

1. Abdel-Aziz F, et al. 2000. Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatology 32:111-115. (Pubitemid 30432374)
2. Abdelwahab S, et al. 2012. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Trans. R. Soc. Trop. Med. Hyg. 106:98-103.
3. Al-Sherbiny M, et al. 2005. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am. J. Trop. Med. Hyg. 73:44-49. (Pubitemid 41278744)
4. Alter H. 1999. Discovery of non-A, non-B hepatitis and identification of its etiology. Am. J. Med. 107:16S-20S.
5. Alter HJ, Bradley DW. 1995. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin. Liver Dis. 15:110-120.
6. Arafa N, et al. 2005. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J. Hepatol. 43:418-424. (Pubitemid 41111422)
7. Baldo V, et al. 2002. Occupational risk of blood-borne viruses in healthcare workers: A 5-year surveillance program. Infect. Control Hosp. Epidemiol. 23:325-327. (Pubitemid 34774362)
8. Bassett SE, et al. 2001. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479-1487. (Pubitemid 32496985)
9. Bowen DG, Walker CM. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952. (Pubitemid 41191670)
10. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J. Gen. Virol. 78(Pt 6):1341-1347. (Pubitemid 27281332)
11. Chang KM, et al. 2001. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
12. Di Bisceglie, A. M. 1997. Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S-38S. (Pubitemid 27388069)
13. Elrefaei M, El-sheikh N, Kamal K, Cao H. 2004. Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt. J. Hepatol. 40: 313-318. (Pubitemid 38115838)
14. El-Zanaty F, Way A. 2009. Egypt Demographic and Health Survey, 2008. Ministry of Health, El-Zanaty and Associates, and Macro International, Cairo, Egypt. http://www.measuredhs.com.
15. Farid A, et al. 2005. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol. 27:189-196. (Pubitemid 40961261)
16. Frank C, et al. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891. (Pubitemid 30137669)
17. Freeman AJ, et al. 2004. Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J. Infect. Dis. 190:1093-1097. (Pubitemid 39186796)
18. + T cells in HIV/HCV versus HCV. Hepatology 40:125-132. (Pubitemid 38868931)
19. Grakoui A, et al. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662. (Pubitemid 37310924)
20. Habib M, et al. 2001. Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology 33:248-253. (Pubitemid 32016908)
21. Hashem M, et al. 2011. Strong hepatitis C virus (HCV)-specific cellmediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children. J. Infect. Dis. 203:854-861.
22. Hofmann F, Michaelis M, Rieger MA, Hasselhorn HM, Berthold H. 1997. Occupational medicine significance of hepatitis C in health care employees. Gesundheitswesen 59:452-460. (In German.
23. Houghton M. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunol. Rev. 239:99-108.
24. Kamal SM, et al. 2004. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J. Virol. 78:12252-12258. (Pubitemid 39458745)
25. Kamal SM, et al. 2001. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J. Infect. Dis. 184:972-982. (Pubitemid 32955113)
26. + T cell responses in HCV and Schistosoma mansoni coinfection: Relation to progression of liver fibrosis. J. Infect. Dis. 189:1140-1150. (Pubitemid 38457236)
27. Kennedy PT, et al. 2006. The influence of T cell cross-reactivity on HCV-peptide specific human T cell response. Hepatology 43:602-611.
28. Kosgeroglu N, Ayranci U, Vardareli E, Dincer S. 2004. Occupational exposure to hepatitis infection among Turkish nurses: Frequency of needle exposure, sharps injuries and vaccination. Epidemiol. Infect. 132:27-33. (Pubitemid 38240069)
29. Kubitschke A, et al. 2007. Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia. Eur. J. Clin. Invest. 37:54-64. (Pubitemid 44934773)
30. Lanphear BP, et al. 1994. Hepatitis C virus infection in healthcare workers: Risk of exposure and infection. Infect. Control Hosp. Epidemiol. 15: 745-750.
31. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52. (Pubitemid 32634271)
32. +-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76:6104-6113. (Pubitemid 34556305)
33. Medhat A, et al. 2002. Hepatitis c in a community in Upper Egypt: Risk factors for infection. Am. J. Trop. Med. Hyg. 66:633-638.
34. Mehta SH, et al. 2002. Protection against persistence of hepatitis C. Lancet 359:1478-1483. (Pubitemid 34457766)
35. Meky FA, et al. 2006. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin. Infect. Dis. 42:628-633. (Pubitemid 43271375)
36. Meyer MF, et al. 2007. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol. Infect. 135:274-280. (Pubitemid 46322066)
37. Mizukoshi E, et al. 2008. Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J. Infect. Dis. 198:203-212. (Pubitemid 352019285)
38. Osburn WO, et al. 2010. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138:315-324.
39. Post JJ, et al. 2004. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis. 189: 1846-1855. (Pubitemid 38657221)
40. +T cells by flow cytometry: Correlation with clinical disease stages. Hepatology 35:190-198. (Pubitemid 34032560)
41. Scognamiglio P, et al. 1999. Presence of effector CD8+T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 162:6681-6689. (Pubitemid 29309393)
42. Seeff LB. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-46. (Pubitemid 35253462)
43. Shata MT, et al. 2003. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 314:601-616. (Pubitemid 37209981)
44. + T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:1645-1655. (Pubitemid 36745340)
45. Strickland GT. 2006. Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43: 915-922. (Pubitemid 43724616)
46. Strickland GT, et al. 2002. Role of hepatitis C infection in chronic liver disease in Egypt. Am. J. Trop. Med. Hyg. 67:436-442. (Pubitemid 35303870)
47. Thomson M, et al. 2003. The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J. Virol. 77:862-870. (Pubitemid 36055508)
48. Torresi J, Johnson D, Wedemeyer H. 2011. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J. Hepatol. 54:1273-1285.
49. Waked IA, et al. 1995. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut 37:105-107.
50. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-11400. (Pubitemid 33063230)
51. Williams R. 2006. Global challenges in liver disease. Hepatology 44:521-526. (Pubitemid 44433707)
52. Zeremski M, et al. 2009. Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J. Viral Hepat. 16:10-20.